市場調查報告書
商品編碼
1468067
2024-2032 年按組件、部署類型、企業規模、應用程式和區域分類的 Epigree 軟體市場報告Epedigree Software Market Report by Component, Deployment Type, Enterprise Size, Application, and Region 2024-2032 |
IMARC Group年,全球頂級軟體市場規模達50億美元。製藥業對可序列化、先進技術整合以及電子商務平台擴張的需求不斷成長,是推動市場發展的一些關鍵因素。
Epedigree 軟體保存藥品所有權變更的電子記錄,用於藥品認證。它允許對產品和訂單進行單一查看,並有助於保護消費者免受受污染的藥品和假藥的侵害。它提供高水準的準確性,保護品牌價值,提高營運效率,確保合規性,並降低勞動力和庫存成本。它實施起來簡單快捷,提高了藥品供應鏈的安全性,並實現了最低的譜繫管理總成本。目前,由於數位化的快速發展、網際網路連接的增加以及智慧型設備的不斷普及,製藥業電子商務平台的擴張正在推動全球對基礎軟體的需求。
為了解決假冒問題,對可序列化的需求不斷成長,這是世界各地對優質軟體需求增加的主要因素之一。此外,各種臨床研究和外包公司擴大採用 epedgree 軟體,有利於市場成長。此外,聯邦機構、政府和製藥公司等監管機構為減少藥品製造和產品轉移而實施的嚴格法規也促進了市場成長。除此之外,對整個製藥供應鏈的智慧化和安全保護的需求也在增加。再加上先進技術的不斷整合,包括快速響應(QR)碼、條碼、雲端運算、進階分析、巨量資料和無線射頻識別(RFID)、物聯網(IoT)與製藥供應鏈,正在推動市場成長。主要參與者正在整合虛擬助理、擴增實境 (AR)、機器學習 (ML) 和虛擬實境 (VR),以支援在供應鏈網路和製藥生產中使用尖端系統。這些技術解決方案有助於藥品從製造和分銷到到達消費者手中的整個過程。它們還可以實現更好的庫存管理,並降低庫存維護、產品浪費和藥品儲存的成本。此外,基於雲端的解決方案和區塊鏈技術的結合,透過端到端的品質控制解決方案使整個供應鏈變得更加智慧和高效,正在對市場產生積極影響。除此之外,維持複雜的藥品供應鏈完整性的日益成長的必要性正在為市場創造積極的前景。
The global epedigree software market size reached US$ 5.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.02% during 2024-2032. The increasing need for serializability, integration of advanced technologies, and the expansion of e-commerce platforms in the pharmaceutical sector represent some of the key factors driving the market.
Epedigree software keeps an electronic record of changes in the ownership of a pharmaceutical product for drug authentication. It allows a single view of the product and order and aids in protecting consumers from contaminated medicine and counterfeit drugs. It provides a high level of accuracy, protects brand value, enhances operational efficiency, guarantees compliance, and lowers labor and inventory costs. It is easy and fast to implement, improves the pharmaceutical supply chain security, and delivers the lowest total cost of pedigree management. At present, the expansion of e-commerce platforms in the pharmaceutical sector on account of rapid digitization, increasing internet connectivity, and the rising penetration of smart devices is driving the demand for epedigree software across the globe.
The rising need for serializability to tackle counterfeiting represents one of the major factors increasing the demand for epedigree software around the world. Moreover, the rising adoption of epedigree software by various clinical research and outsourcing companies is favoring the market growth. In addition, stringent regulations imposed by regulatory authorities like federal agencies, governments, and pharmaceutical companies to reduce drug fabricating and product diversion are contributing to the market growth. Apart from this, there is an increase in demand for smartening and securing the overall pharma supply chain. This, coupled with the rising integrating of advanced technologies, including quick response (QR) codes, barcodes, cloud computing, advanced analytics, big data, and radio frequency identification (RFID), the internet of things (IoT) with pharma supply chain, is impelling the market growth. Key players are incorporating virtual assistants, augmented reality (AR), machine learning (ML), and virtual reality (VR) to support the appropriation of cutting-edge systems across the supply chain network and pharma productions. These technological solutions assist in the processing of a pharmaceutical drug from manufacturing and distribution until the drug reaches the consumer. They also enable better stock management and lead to the reduction in costs incurred in terms of inventory maintenance, wastage of products, and storage of drugs. Furthermore, the incorporation of cloud-based solutions and blockchain technology for making the whole supply chain smarter and more efficient with end-to-end quality control solutions is influencing the market positively. Besides this, the growing necessity to maintain the integrity of the complex pharma supply chain is creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each segment of the global epedigree software market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on component, deployment type, enterprise size, and application.
Software
Services
The report has provided a detailed breakup and analysis of the epedigree software market based on the component. This includes software and services.
On-premises
Cloud-based
A detailed breakup and analysis of the epedigree software market based on the deployment type has also been provided in the report. This includes on-premises and cloud-based. According to the report, on-premises accounted for the largest market share.
Small and Medium-sized Enterprises
Large Enterprises
A detailed breakup and analysis of the epedigree software market based on the enterprise size has also been provided in the report. This includes small and medium-sized, and large enterprises. According to the report, large enterprise accounted for the largest market share.
Hospital Pharmacies
Retail Pharmacies
Pharmaceutical Factory
Online Pharmacies
Others
A detailed breakup and analysis of the epedigree software market based on the application has also been provided in the report. This includes hospital pharmacies, retail pharmacies, pharmaceutical factory, online pharmacies, and others. According to the report, pharmaceutical factories accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for epedigree software. Some of the factors driving the North America epedigree software market included a considerable reliance on e-commerce platforms, a rising number of clinical researches, and stringent regulations imposed by governing authorities to reduce drug fabricating and product diversion.
The report has also provided a comprehensive analysis of the competitive landscape in the global epedigree software market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Antares Vision Spa, Axway, SAP SE, and TraceLink Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report